Preliminary observations of oral nicotin
β
John Robert Ingram; John Rhodes; Brian K Evans; Dr. Gareth A. O. Thomas
π
Article
π
2005
π
John Wiley and Sons
π
English
β 200 KB
## Background: Transdermal nicotine provides benefit in active ulcerative colitis but is often associated with adverse events (aes). an oral formulation has been developed to minimize aes. this study was undertaken to make initial observations on the safety and tolerance of oral nicotine therapy in